Related Articles
EGFR as paradoxical predictor of chemosensitivity and outcome among triple-negative breast cancer
Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer
Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome
Molecular subtype can predict the response and outcome of Chinese locally advanced breast cancer patients treated with preoperative therapy
Usefulness of miRNA profiles for predicting pathological responses to neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2‑positive breast cancer